Ageotype Portal, developed by R42 Group, LLC, is a beta longevity platform that brings health information from multiple sources into an interactive view. It helps users explore how different body systems—including the brain, heart, metabolism, and immune system—may be aging at different rates. A free, approximately five-minute questionnaire provides an estimated biological age and an Ageotype classification, with no login required to begin.

Users can build a broader longevity profile through Bronze, Silver, or Gold diagnostic tiers offering precision lab work, advanced imaging, and genomic analysis. The portal also supports uploading reports from more than 12 providers, including blood tests, MRIs, metabolomics, and microbiome assessments. Its AI tools cross-reference data to present plain-language summaries, personalized insights, and visual timelines. Additional features include meal scanning, medication logging, goal tracking, and achievement badges.

A demo profile showcases whole-body and brain MRI reports, multi-cancer early detection, metabolomics-based aging and organ scores, and gut microbiome findings. R42 Group also promotes longevity events, a retreat, and a Stanford certificate course.